CiteFacts · FDA Drug Shortages · FDA source
Quinapril Hydrochloride Tablet
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Aurobindo Pharma USA | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Unavailable | 06/02/2026 |
| Aurobindo Pharma USA | Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) | Unavailable | 06/02/2026 |
| Aurobindo Pharma USA | Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) | Unavailable | 06/02/2026 |
| Aurobindo Pharma USA | Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) | Unavailable | 06/02/2026 |
| Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) | Available | 08/04/2026 |
| Chartwell Molecular Holdings LLC | Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) | Available | 08/04/2026 |
| Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) | Unavailable | 08/18/2026 |
| Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) | Unavailable | 08/18/2026 |
| Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) | Unavailable | 08/18/2026 |
| Lupin Pharmaceuticals, Inc. | Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) | Unavailable | 08/18/2026 |
| Pfizer Inc. | Accupril, Tablet, 10 mg (NDC 0071-0530-23) | Not stated | 10/01/2025 |
| Pfizer Inc. | Accupril, Tablet, 10 mg (NDC 0071-0530-23) | Unavailable | 08/07/2026 |
| Pfizer Inc. | Accupril, Tablet, 20 mg (NDC 0071-0532-23) | Not stated | 10/01/2025 |
| Pfizer Inc. | Accupril, Tablet, 20 mg (NDC 0071-0532-23) | Unavailable | 08/07/2026 |
| Pfizer Inc. | Accupril, Tablet, 40 mg (NDC 0071-0535-23) | Unavailable | 08/07/2026 |
| Pfizer Inc. | Accupril, Tablet, 40 mg (NDC 0071-0535-23) | Not stated | 10/01/2025 |
| Pfizer Inc. | Accupril, Tablet, 5 mg (NDC 0071-0527-23) | Not stated | 10/01/2025 |
| Pfizer Inc. | Accupril, Tablet, 5 mg (NDC 0071-0527-23) | Unavailable | 08/07/2026 |
| Solco Healthcare US, LLC | Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) | Unavailable | 06/29/2026 |
| Solco Healthcare US, LLC | Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) | Unavailable | 06/29/2026 |
| Solco Healthcare US, LLC | Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) | Unavailable | 06/29/2026 |
| Solco Healthcare US, LLC | Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) | Unavailable | 06/29/2026 |
Source facts
Grouped generic ingredient: Quinapril Hydrochloride Tablet · 24 package records · Latest FDA row update: 10/01/2025
Therapeutic categories: Cardiovascular
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.